Fraxiparine

Fraxiparine is a pharmaceutical product containing Nadroparin Calcium, used for intravenous administration. It belongs to the class of low-molecular-weight heparins, commonly utilized for anticoagulation therapy.

Fraxiparine, containing Nadroparin Calcium, is primarily used for anticoagulation purposes. This medication is often prescribed to prevent blood clots in various medical conditions, such as during surgery or for patients with limited mobility. It is also used to treat existing blood clots, helping to reduce the risk of further clotting and complications.

Fraxiparine may cause common effects such as bruising, bleeding, and pain at the injection site. Some users might experience more severe reactions like allergic responses or significant bleeding, which should be monitored closely.

Fraxiparine should be handled with care, especially by individuals with a history of bleeding disorders or those undergoing certain medical procedures. It is essential to follow healthcare provider instructions regarding administration and monitoring. Regular blood tests may be required to ensure safe and effective use.

Fraxiparine may interact with other medications, particularly those that affect blood clotting, such as aspirin or other anticoagulants. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before combining Fraxiparine with other treatments.